Virtual Library

Start Your Search

W. Choi



Author of

  • +

    P2.02 - Poster Session/ Treatment of Localized Disease – NSCLC (ID 210)

    • Event: WCLC 2015
    • Type: Poster
    • Track: Treatment of Localized Disease - NSCLC
    • Presentations: 1
    • +

      P2.02-040 - Clinical Outcome of Fiducial-Less CyberKnife Stereotactic Ablative Body Radiotherapy for Stage I Non-Small Cell Lung Cancer (ID 1221)

      09:30 - 09:30  |  Author(s): W. Choi

      • Abstract
      • Slides

      Background:
      CyberKnife[TM] is a dedicated system for radiosurgery, with a capability of real-time tumor tracking; Synchrony[®] Respiratory tracking system. Xsight[®] lung tracking system with Synchrony[®] Respiratory tracking system make possible direct lung tumor tracking without fiducial markers. However, there was no establised indication of fiducial-less Cyberknife Radiosurgery (CKRS). So, to ascertain whether indication of fiducial-less CKRS can be extended or not , we had evaluated treatment outcome of fiducial-less CKRS using Xsight[®] lung tracking system at AMC and tested accuracy of CyberKnife Xsight[®] lung tracking system without fiducial marker by phantom experiment. Here are the results of fiducial-less CKRS using Xsight[®] lung tracking system for stage I NSCLC.

      Methods:
      From June 2011 to November 2013, 58 patients received Cyberknife Radiosurgery to lung at Asan medical center. We retrospectively reviewed records of 44 patients of stage I lung cancer exclude 14 patients (6 with Advanced NSCLC, 6 with Rec. lung cancer within 5 years, 2 with lung metastasis from other primary cancer). All analyses were performed using SPSS, version 21.

      Results:
      Median age at diagnosis was 75 years. Man was 37 (84.1%). Most of patients were inoperable primary lung cancer with poor PFT (mean FEV1: 63.0 % (range 24-138%), mean DLCo : 50.8 % (range 43- 96 %)) or comorbidity or old age. Clinical stage was IA in 30 (68.2 %), IB in 14 (31.8 %) patients. Mean tumor size was 2.6 cm. (1.2 cm-4.8cm, smaller than 2 cm was 12 (27.3%)) Radiation dose were 48 – 60 Gy per 3 - 4 fx. With median follow-up of 23.1 months, there were LR in 3 patients ( 1Y LRFSR : 94.9%, 2Y LRFSR : 90.4% ) and DM in 13 patients (DM only, n= 7). All patients tolerated the radiosurgery well, only 2 patients had grade 3 dyspnea (1 of 2 suffered from ILD aggravation). Most common complication was RT-induced fibrosis & pneumonitis. Eight patients have died due to cancer progression.(1Y OSR : 86%, 2Y OSR : 80.3%)

      Conclusion:
      Fiducial-less cyberknife radiosurgery showed good local tumor control and survival in medically inoperable stage I NSCLC, which was comparable with that of linac-based stereotactic body radiosurgery or CKRS with fiducial marker. Even though there were some limitations to apply Xsight [®] lung tracking system without fiducial marker, but it could be used safely in relatively small tumor located in not recommended site.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.